FibroBiologics Inc. (NASDAQ: FBLG) Stock Information | RedChip

FibroBiologics Inc. (NASDAQ: FBLG) Listen to this Section


$1.18
-0.5400 ( -31.40% ) 535.3K

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Market Data


Open


$1.18

Previous close


$1.72

Volume


535.3K

Market cap


$42.19M

Day range


$1.19 - $1.80

52 week range


$1.19 - $55.00

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
3/a Insider transactions 1 Aug 13, 2024
3/a Insider transactions 1 Aug 13, 2024
3/a Insider transactions 1 Aug 13, 2024
3/a Insider transactions 1 Aug 13, 2024
3/a Insider transactions 1 Aug 13, 2024
3/a Insider transactions 1 Aug 13, 2024
4 Insider transactions 1 Aug 12, 2024
3/a Insider transactions 2 Aug 12, 2024
4 Insider transactions 1 Aug 12, 2024
3/a Insider transactions 1 Aug 12, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.